Results 231 to 240 of about 13,564,204 (314)

Stimulator of interferon genes agonist augmented antitumor immunity of osimertinib in Egfr‐mutated lung cancer

open access: yesMolecular Oncology, EarlyView.
Combining osimertinib with the STING agonist ADU‐S100 activates innate and adaptive immunity to overcome the non‐inflamed microenvironment of Egfr‐mutant lung cancer. This combination increases NK and CD8+ T‐cell infiltration, associated with activation of the STING‐IRF3 pathway and local immunogenic cell death.
Jun Nishimura   +19 more
wiley   +1 more source

Quality Improvement Competencies for Health Care Quality Professionals: Protocol for a Scoping Review. [PDF]

open access: yesJMIR Res Protoc
Shaharuddin N   +7 more
europepmc   +1 more source

Sleep quality and chronotype in primary headache disorders: a nationwide population-based study of 5,311 Polish adults. [PDF]

open access: yesJ Headache Pain
Marschollek K   +4 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy